InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Moran Michael Shawn, Dirigeant. Director active across 1 companies, notably Eagle Pharmaceuticals, INC.. Aggregated, 9 filings have been published. The latest transaction was filed on 28 February 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations9 total
010,400 shares0
Common Stock
SEC:0001209191-22-015024:0·
€29,637742 shares@ €39.941626.9% of flow
Common Stock
SEC:0001209191-22-007222·
€29,637742 shares@ €39.94160.90% mcap13.4% of flow
Common Stock
SEC:0001209191-22-007222:0·
€8,651210 shares@ €41.1937.8% of flow
Common Stock
SEC:0001209191-22-006051·
€8,651210 shares@ €41.1930.26% mcap3.9% of flow
Common Stock
SEC:0001209191-22-006051:0·
€4,03490 shares@ €44.81770.12% mcap1.8% of flow
Common Stock
SEC:0001209191-22-002886:0·
€4,03490 shares@ €44.81773.7% of flow
Common Stock
SEC:0001209191-22-002886·
€67,8791,511 shares@ €44.923561.6% of flow
Common Stock
SEC:0001209191-22-002419·
€67,8791,511 shares@ €44.92352.06% mcap30.8% of flow
Common Stock
SEC:0001209191-22-002419:0·
9 of 9 declarations
About Moran Michael Shawn
Michael Shawn Moran is EVP and Chief Commercial Officer at Eagle Pharmaceuticals, Inc. In this role, he is responsible for the company's commercial strategy and business development. His experience in the pharmaceutical sector enables him to lead initiatives aimed at strengthening the company's market position.
